CPG for Eating Disorders

Variables: depression and/or interpersonal and psychosocial functioning and/orgeneral psychiatric symptomsThere is strong evidence that points to a higher efficacy of CBT-BN vs. wait-list inreducing depression in adults with BN by the end of treatment (3 RCTs; N=87; Agras,1989 222 ; Lee, 1986 218 ; Leitenberg, 1988 223 ; SMD according to random effects model: -1.19; 95% CI: -1.99 to -0.39).There is not sufficient evidence to determine if CBT-BN differs from BT in reducinggeneral psychiatric symptoms (SMD: -0.26; 95% CI: -0.89 to 0.37) and in interpersonaland psychosocial functioning (SMD: -0.21; 95% CI: -0.84 to 0.42) by the end oftreatment (1 RCT; N=39, Fairburn, 1991) 224 .There is not sufficient evidence that CBT-BN differs from BT in general psychiatricsymptoms (SMD: -0.09; 95% CI: -0.79 to 0.61) and interpersonal and psychosocialfunctioning (SMD: 0.14; 95% CI: -0.56 to 0.85) at follow-up (1 RCT; N=32, Fairburn,1991) 224 .There is insufficient evidence that indicates that CBT-BN differs from PDT ininterpersonal and psychosocial functioning (N=41, SMD: -0.39; 95% CI: -1.01 to 0.23)or in general psychiatric symptoms (N= 48, SMD: -0.60; 95% CI: -1.18 to -0.02) by theend of treatment (1 RCT, Garner, 1993) 229There is no evidence or insufficient evidence to determine that CBT-BN differs fromFSP in interpersonal and psychosocial functioning (SMD: -0.47; 95% CI:-1.28 to 0.34)(1 RCT; N=24, Fairburn, 1986) 228 and in general psychiatric symptoms (2 RCTs; N=69;Fairburn, 1986 228 ; Walsh, 1997 233 ; SMD: -0.29; 95% CI: -0.77 to 0.19) by the end oftreatment or at post-treatment follow-up.There is insufficient evidence that CBT-BN treatment vs. GSH differs in terms ofdepression scores by the end of treatment (SMD: 0.55; 95% CI: 0.02 to 1.09) and atpost-treatment follow-up (SMD: 0.38; 95% CI: -0.15 to0.92) (1 RCT; N=55, Bailer,2004) 230 .RCT1 ++RCT1 ++RCT1 ++RCT1 ++RCT1 ++RCT1 ++There is insufficient evidence that individual CBT differs from group CBT in terms of RCTdepression (SMD: 0.09; 95% CI: -0.41 to 0.60), general psychiatric symptoms (SMD: 1 ++0.07; 95% CI: -0.58 to 0.44) and psychosocial and interpersonal functioning (SMD: -0.16; 95% CI: -0.67 to 0.34) by the end of treatment (1 RCT; N=60, Chen, 2003) 232There is insufficient evidence that individual CBT differs from group CBT in terms ofdepression (SMD: 0.28; 95% CI: -0.23 to 0.l79), general psychiatric symptoms (SMD:0.14; 95% CI: -0.37 to 0.64) and psychosocial and interpersonal functioning (SMD:0.46; 95% CI: -0.05 to 0.98) at post-treatment follow-up (1 RCT; N=60, Chen, 2003) 232 .RCT1 ++Other results102CLINICAL PRACTICE GUIDELINE FOR EATING DISORDERS